Mycobacterium Citations List: July 2023

Literature Citations

1. Synthesis, Docking Studies, and Biological Evaluation of Betti Bases as Promising Anti-tubercular Agents. Acharya, P., M.M.V. Ramana, N. Korgavkar, G. Pavale, and M. Upadhyay. Letters in Drug Design & Discovery, 2023. 20(6): p. 724-737. ISI[001015570600011].
[WOS]. TB_07_2023.

2. Synthesis of New 4'-(Substituted phenyl)spiro[indoline-3,3'-[1,2,4]triazolidine]-2,5'-diones as Antimicrobial, Antitubercular, and Antifungal Agents: An Insight into the ADME and Toxicity Prediction as Well as in-Silico Molecular Docking Studies. Ahsan, M.J., A. Ali, A. Ali, O. Afzal, M. Yusuf, A.S.A. Altamimi, O. Sharma, M.A. Alossaimi, and M.A. Bakht. Journal of Molecular Structure, 2023. 1290. ISI[001014823000001].
[WOS]. TB_07_2023.

3. Prenylated Isoflavanones with Antimicrobial Potential from the Root Bark of Dalbergia melanoxylon. Chalo, D.M., K. Franke, V.A. Nchiozem-Ngnitedem, E. Kakudidi, H. Origa-Oryem, J. Namukobe, F. Kloss, A. Yenesew, and L.A. Wessjohann. Metabolites, 2023. 13(6): 678. PMID[37367838]. PMCID[PMC10304121].
[PubMed]. TB_07_2023.

4. Oridonin Inhibits Mycobacterium marinum Infection-induced Oxidative Stress in Vitro and in Vivo. Chen, G., Z. Yang, D. Wen, P. Li, Q. Xiong, and C. Wu. Pathogens, 2023. 12(6): 799. PMID[37375489]. PMCID[PMC10301349].
[PubMed]. TB_07_2023.

5. High-throughput Screen with the L,D-transpeptidase Ldt(Mt2) of Mycobacterium tuberculosis Reveals Novel Classes of Covalently Reacting Inhibitors. de Munnik, M., P.A. Lang, F. De Dios Anton, M. Cacho, R.H. Bates, J. Brem, B. Rodríguez Miquel, and C.J. Schofield. Chemical Science, 2023. 14(26): p. 7262-7278. PMID[37416715]. PMCID[PMC10321483].
[PubMed]. TB_07_2023.

6. Synthesis, Characterization, 'ADMET-SAR' Prediction, DPPH Assay, and Anti-mycobacterium Study of 4-[(Substituted benzyl)amino]benzo hydrazides and its Hydrazones as the Acyl-CoA Carboxylase, AccD5 Inhibitors. Desale, V.J., S.N. Mali, B.R. Thorat, R.S. Yamgar, S.V. Dharanguttikar, V.R. Dharanguttikar, S. Chtita, M. Oliveira, and J.N. Cruz. Current Computer-Aided Drug Design, 2023. 19(4): p. 300-312. PMID[36578253].
[PubMed]. TB_07_2023.

7. Inhibition of Mycobacterium tuberculosis InhA (Enoyl-acyl Carrier Protein Reductase) by Synthetic Chalcones: A Molecular Modelling Analysis and in-Vitro Evidence. Dhivya, L.S., S. Sarvesh, and A.S. S. Journal of Biomolecular Structure and Dynamics, 2023. 41(12): p. 5399-5417. PMID[35751128].
[PubMed]. TB_07_2023.

8. Synthesis of New Amide Linked Biphenoloxy 1,2,3-triazoles as Antitubercular and Antimicrobial Agents. Dhumal, S.T., T.R. Deshmukh, K.P. Haval, V.S. Krishna, D. Sriram, V.M. Khedkar, N. Rehman, P.P. Dixit, and R.A. Mane. Polycyclic Aromatic Compounds, 2023. ISI[001016041800001].
[WOS]. TB_07_2023.

9. Side Chain-modified Benzothiazinone Derivatives with Anti-mycobacterial Activity. Fan, D., B. Wang, G. Stelitano, K. Savková, O. Riabova, R. Shi, X. Wu, L.R. Chiarelli, K. Mikušová, V. Makarov, Y. Lu, Y. Hong, and C. Qiao. Biomedicines, 2023. 11(7). PMID[37509615]. PMCID[PMC10377601].
[PubMed]. TB_07_2023.

10. Development, Characterization and Anti-mycobacterium tuberculosis Activity of Solid Lipid Nanoparticles for Oral Piper corcovadensis Roots Extract Delivery. Fernandez, C.M.M., S.A. Kleinubing, T.K. Karam, F.B. Lorenzetti, C.T. Palomo, B.P.M. de Oliveira, O.H. Goncalves, Z.C. Gazim, M.B. Romagnolo, K.R. Caleffi-Ferracioli, R.B.D. Scodro, M.M.D. Lima, T.U. Nakamura, C.V. Nakamura, and B.P. Dias. Boletin Latinoamericano Y Del Caribe De Plantas Medicinales y Aromaticas, 2023. 22(6): p. 821-836. ISI[001015805400005].
[WOS]. TB_07_2023.

11. 2,6-Disubstituted 7-(naphthalen-2-ylmethyl)-7H-purines as a New Class of Potent Antitubercular Agents Inhibiting DprE1. Finger, V., T. Kucera, R. Kafkova, L. Muckova, R. Dolezal, J. Kubes, M. Novak, L. Prchal, L. Lakatos, M. Andrs, M. Hympanova, J. Marek, M. Kufa, V. Spiwok, O. Soukup, E. Mezeiova, J. Janousek, L. Nevosadova, M. Benkova, R.R.A. Kitson, M. Kratky, S. Bősze, K. Mikusova, R. Hartkoorn, J. Roh, and J. Korabecny. European Journal of Medicinal Chemistry, 2023. 258: 115611. PMID[37421887].
[PubMed]. TB_07_2023.

12. Characterization of Two Novel Inhibitors of the Mycobacterium tuberculosis Cytochrome bc1 Complex. Gries, R., M. Dal Molin, J. Chhen, E. van Gumpel, V. Dreyer, S. Niemann, and J. Rybniker. Antimicrobial Agents and Chemotherapy, 2023. 67(7): e0025123. PMID[37358461]. PMCID[PMC10353358].
[PubMed]. TB_07_2023.

13. Tetrahydrobenzo[h]quinoline Derivatives as a Novel Chemotype for Dual Antileishmanial-antimalarial Activity Graced with Antitubercular Activity: Design, Synthesis and Biological Evaluation. Ibrahim, T.M., G. Abada, M. Dammann, R.M. Maklad, W.M. Eldehna, R. Salem, M.M. Abdelaziz, R.A. El-Domany, A.A. Bekhit, and F.M. Beockler. European Journal of Medicinal Chemistry, 2023. 257: 115534. PMID[37269671].
[PubMed]. TB_07_2023.

14. Discovery and Biological Evaluation of an Adamantyl-amide Derivative with Likely MmpL3 Inhibitory Activity. Kapp, E., H. Calitz, E.M. Streicher, A. Dippenaar, S. Egieyeh, A. Jordaan, D.F. Warner, J. Joubert, S.F. Malan, and S.L. Sampson. Tuberculosis, 2023. 141: 102350. PMID[37244249].
[PubMed]. TB_07_2023.

15. Mechanochemical Studies on Coupling of Hydrazines and Hydrazine Amides with Phenolic and Furanyl Aldehydes-hydrazones with Antileishmanial and Antibacterial Activities. Kapusterynska, A., C. Bijani, D. Paliwoda, L. Vendier, V. Bourdon, N. Imbert, S. Cojean, P.M. Loiseau, D. Recchia, V.C. Scoffone, G. Degiacomi, A. Akhir, D. Saxena, S. Chopra, V. Lubenets, and M. Baltas. Molecules, 2023. 28(13): 5284. PMID[37446945]. PMCID[PMC10343660].
[PubMed]. TB_07_2023.

16. Identification of Novel Antimicrobial Compounds Targeting Mycobacterium tuberculosis Shikimate Kinase Using in Silico Hierarchical Structure-based Drug Screening. Kawamoto, S., C. Hori, H. Taniguchi, S. Okubo, and S. Aoki. Tuberculosis, 2023. 141: 102362. PMID[37311288].
[PubMed]. TB_07_2023.

17. In Vitro Susceptibility Testing of Tetracycline-class Antibiotics against Slowly Growing Non-tuberculous Mycobacteria. Li, A., Z. Tan, S. He, and H. Chu. Clinical and Experimental Pharmacology and Physiology, 2023. 50(7): p. 604-609. PMID[37086075].
[PubMed]. TB_07_2023.

18. Evaluation of Antituberculosis Activity and In Silico Properties of Oxymethylene-cyclo-1,3-diones. Lin, M.L., M.Y. Yang, and M.L. Dong. Chemistry & Biodiversity, 2023. 20(7): e202300779. PMID[37306664].
[PubMed]. TB_07_2023.

19. Pd(II)dipyrrinato Complexes: Synthesis, Crystal Structure and their Antibacterial Applications. Manav, N., J. Chavda, S. Kidwai, R. Singh, S. Mori, and I. Gupta. Journal of Porphyrins and Phthalocyanines, 2023. 27(07n10): p. 1304-1312. ISI[001010565600002].
[WOS]. TB_07_2023.

20. The Synthesis and Biological Evaluation of 2-(1H-Indol-3-yl)quinazolin-4(3H)-One Derivatives. Mendogralo, E.Y., L.Y. Nesterova, E.R. Nasibullina, R.O. Shcherbakov, A.G. Tkachenko, R.Y. Sidorov, M.A. Sukonnikov, D.A. Skvortsov, and M.G. Uchuskin. Molecules, 2023. 28(14): 5348. PMID[37513221]. PMCID[PMC10384628].
[PubMed]. TB_07_2023.

21. Centella asiatica Extract Inhibits Mycobacterium tuberculosis in Rat Tuberculosis Models. Mustika, A., M. Agil, S.A. Sudjarwo, and N.M. Mertaniasih. Respirology, 2023. 28: p. 389-390. ISI[001002451700666].
[WOS]. TB_07_2023.

22. Synthesis, Biological Screening and in Silico Studies of New N-Phenyl-4-(1,3-diaryl-1H-pyrazol-4-yl)thiazol-2-amine Derivatives as Potential Antifungal and Antitubercular Agents. Nandurkar, Y., M.R. Bhoye, D. Maliwal, R.R.S. Pissurlenkar, A. Chavan, S. Katade, and P.C. Mhaske. European Journal of Medicinal Chemistry, 2023. 258: 115548. PMID[37307623].
[PubMed]. TB_07_2023.

23. In-silico and In-vitro Assessments of Some Fabaceae, Rhamnaceae, Apocynaceae, and Anacardiaceae Species against Mycobacterium tuberculosis H37Rv and Triple-negative Breast Cancer Cells. Nyambo, K., F. Adu-Amankwaah, K.I. Tapfuma, L. Baatjies, L. Julius, L. Smith, M. Ngxande, K. Govender, L. Mabasa, A. Traore, M.V. Masiphephethu, I.S. Niang, and V. Mavumengwana. BMC Complementary Medicine and Therapies, 2023. 23(1): 219. PMID[37393246]. PMCID[PMC10314437].
[PubMed]. TB_07_2023.

24. Mycobacterium tuberculosis Inhibitors Based on Arylated Quinoline Carboxylic acid Backbones with anti-Mtb Gyrase Activity. Quimque, M.T.J., A.D. Go, J.A.K. Lim, W.S. Vidar, and A.P.G. Macabeo. International Journal of Molecular Sciences, 2023. 24(14): 11632. PMID[37511390]. PMCID[PMC10380224].
[PubMed]. TB_07_2023.

25. Isoniazid-N-acylhydrazones as Promising Compounds for the Anti-tuberculosis Treatment. Sampiron, E.G., L.L. Calsavara, V.P. Baldin, D.C. Montaholi, A.L.D. Leme, D.Y. Namba, V.G. Alves Olher, K.R. Caleffi-Ferraciolli, R.F. Cardoso, V.L.D. Siqueira, F. Vandresen, and R.B.L. Scodro. Tuberculosis, 2023. 141: 102363. PMID[37311289].
[PubMed]. TB_07_2023.

26. Polypharmacological Repurposing Approach Identifies Approved Drugs as Potential Inhibitors of Mycobacterium tuberculosis. Singh, J., N. Quadir, S. Vashishtha, A. Chakraborty, A. Alam, B. Kundu, U. Ahmad, D. Sundar, N.Z. Ehtesham, and S.E. Hasnain. Biochemical Journal, 2023. 480(14): p. 1079-1096. PMID[37306466].
[PubMed]. TB_07_2023.

27. Design, Synthesis and Antitubercular Activity of Novel N-(Amino)piperazinyl benzothiazinones with Improved Safety. Wang, A., N. Du, H. Song, Y. Zhang, X. Zhong, J. Wu, T. Xue, M. Liu, B. Wang, K. Lv, and Y. Lu. European Journal of Medicinal Chemistry, 2023. 258: 115545. PMID[37300914].
[PubMed]. TB_07_2023.

28. Synthesis, Antimycobacterial Evaluation, and Molecular Docking Study of 1,2,4-triazole Derivatives. Xia, M.Y., Y.X. Cai, J.X. Chen, X. Zhao, H.M. Dong, and Z.C. Yang. Journal of Enzyme Inhibition and Medicinal Chemistry, 2023. 38(1): 2229070. PMID[37381729]. PMCID[PMC10312031].
[PubMed]. TB_07_2023.

29. Synthesis, Structure, ADME and Biological Activity of Three 2,6-Disubstituted thiosemicarbazone Derivatives. Ziembicka, D., A. Olczak, K. Gobis, I. Korona-Głowniak, A. Pietrzak, E. Augustynowicz-Kopeć, A. Głogowska, M. Zaborowski, and M. Szczesio. Acta Crystallographica. Section C, Structural Chemistry, 2023. 79(Pt 7): p. 283-291. PMID[37368648].
[PubMed]. TB_07_2023.

Patent Citations

This month, no relevant Mycobacterium patents were identified.